UnknownNCT05480293
This Study Will Compare the Efficacy and Safety of SCT510A Administered by Intravitreal Injection (IVT) With Ranibizumab in Patients With wAMD
PHASE3 · 446 planned enrolment
- Countries listed
- 1
- Registry update
- February 16, 2023
immortal.lifeTrial registrations containing the exact intervention label SCT510A.
No aliases or equivalent products have been inferred.
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →PHASE3 · 446 planned enrolment
PHASE1 · PHASE2 · 66 planned enrolment